8-K: Aclarion Inc. Enters $10 Million At-The-Market Offering Agreement with Ascendiant Capital Markets
At-The-Market Offering Agreement
Aclarion Inc. has entered into an agreement with Ascendiant Capital Markets to sell up to $10 million of its common stock through an at-the-market offering.
Summary
- Aclarion Inc. has established an at-the-market (ATM) offering agreement with Ascendiant Capital Markets, LLC, to sell up to $10 million of its common stock.
- The company will control the timing and amount of shares sold, with a maximum of $10 million in aggregate sales.
- Ascendiant Capital Markets will act as the sales agent, using commercially reasonable efforts to sell the shares.
- The sales will be conducted under an existing shelf registration statement filed with the SEC.
- The company will pay Ascendiant a commission of up to 3% of the gross proceeds from each sale.
- The company has also agreed to provide customary indemnification and contribution rights to the agent.
- The company is not obligated to sell any shares under the agreement and both parties have the right to terminate the agreement.
Sentiment
Score: 6
Explanation: The document is neutral to slightly positive. It outlines a standard financial transaction that provides the company with flexibility, but also carries the risk of dilution. The sentiment is not overly positive or negative.
Positives
- The agreement provides Aclarion with a flexible way to raise capital.
- The company retains control over the timing and amount of shares sold.
- The agreement allows for sales to be made at market prices.
- The company is not obligated to sell any shares under the agreement.
Negatives
- The company will pay a commission of up to 3% of the gross proceeds from each sale.
- The agreement could potentially dilute existing shareholders if a large number of shares are sold.
- There is no guarantee that the company will be able to sell all $10 million of shares.
Risks
- The company may not be able to sell all of the shares under the agreement.
- The sale of shares could dilute existing shareholders.
- The company is subject to market risk and the price of its shares could decline.
- The company is subject to the risk that the agent may terminate the agreement.
Future Outlook
The company intends to use the net proceeds as described in the prospectus, but the specific use is not detailed in this document.
Industry Context
At-the-market offerings are a common method for companies to raise capital, particularly for those with existing shelf registrations. This allows for flexibility in timing and pricing of share sales.
Comparison to Industry Standards
- The 3% commission is within the typical range for at-the-market offerings.
- The $10 million offering size is relatively small compared to some larger companies, but is appropriate for a company of Aclarion's size and stage.
- The use of a shelf registration statement is a standard practice for companies that frequently access the capital markets.
- Comparable companies that have used ATM offerings include Xometry, Inc. and Beyond Meat, Inc., although these companies are in different sectors.
Stakeholder Impact
- Shareholders may experience dilution if a large number of shares are sold.
- The company will have access to additional capital to fund its operations.
- The company's financial position may be strengthened by the capital raise.
Next Steps
- Aclarion will begin selling shares through Ascendiant Capital Markets as per the terms of the agreement.
- The company will monitor market conditions and determine the timing and amount of shares to be sold.
- The company will file necessary reports with the SEC regarding the sale of shares.
Key Dates
| Date | Description |
|---|---|
| September 9, 2024 | Initial filing date of the Form S-3 registration statement with the SEC. |
| September 23, 2024 | The SEC declared the Form S-3 registration statement effective. |
| September 24, 2024 | Date of the At-The-Market Issuance Sales Agreement and the prospectus supplement. |
Keywords
at-the-market offering, common stock, capital raise, Ascendiant Capital Markets, securities, placement, sales agreement, Aclarion Inc.
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.